Guelph, ON – January 20, 2016
Mirexus Biotechnologies Inc. (“Mirexus”), a client of GreenSky Capital Inc., recently made two critical announcements.
First, Trevor Jones, P. Eng. joined Mirexus as Vice President, Engineering. Trevor has executive experience in R&D, Engineering, Sales and Operations. “We have been looking for some time for a candidate to lead our efforts to finalize the development of our manufacturing process, leading to the construction of our first manufacturing plant in the near future” says Phil Whiting, President & CEO of Mirexus. “We needed someone with a breadth of business and technical skills to lead this from concept to reality while ensuring we continue to meet customer demand for our product in the meantime. Trevor has the right skills and background and we are thrilled that he decided to join Mirexus”.
Second, the National Resource Council Canada (NRC) announced a partnership with Glysantis Inc., a Mirexus subsidiary specializing in biomedical nanomaterial applications, to study how Glysantis’s proprietary material NanoGlysTM could be used as a vaccine adjuvant, drug delivery vehicle, and medical imaging agent. The first phase of testing will confirm the safety of NanoGlys™, as well as the nanoparticle’s ability to reach targeted biological sites and be cleared away thereafter. Future studies will explore if NanoGlys™ can successfully deliver chemotherapeutic agents directly to diseased cells or tissue, and confirm its therapeutic efficacy.
Full press releases from Mirexus and NRC may be seen at the following URLs.
About Mirexus Biotechnologies Inc.
Mirexus Inc. is a safe and natural biomaterials company based in Guelph, Ontario that is commercializing a novel nanotechnology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to biomedical applications in animal and human health. This technology was originally developed at the University of Guelph in the laboratories of Professor John Dutcher.
About GreenSky Capital Inc.
GreenSky Capital is a boutique corporate finance advisory firm based in Toronto, delivering customized financial solutions to small and medium sized technology firms. GreenSky mandates are long-term partnerships with high growth potential companies and dedicated entrepreneurs. GreenSky principals bring together a unique combination of experience in operations, law and finance. As an operator’s investment bank, GreenSky has the ability to bring extensive capital markets experience into a real-world context.